Fool.com Headlines: 2 FDA Decisions You Can't Afford to Miss This Week

Fool.com Headlines Fool.com Headlines

2 FDA Decisions You Can't Afford to Miss This Week Apr 28th 2013, 15:45 A small-cap biotech company looking for its first Food and Drug Administration approval and a potentially game-changing renal cancer drug are going before the firing squad this week.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions